A Clinical Investigation to Confirm the Ability of MammoWave in Breast Lesions Detection
A Clinical Investigation (multicentric, Single Arm, Prospective, Stratified) to Confirm the Ability of MammoWave (microwave Mammogram) in Breast Lesions Detection
Sponsor: Umbria Bioengineering Technologies
A NA clinical study on Breast Cancer, this trial is actively recruiting participants. The trial is conducted by Umbria Bioengineering Technologies and has accumulated 11 data snapshots since 2023. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
11 versions recorded-
Feb 2025 — Present [monthly]
Recruiting NA
-
Sep 2024 — Feb 2025 [monthly]
Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Recruiting NA
-
Jun 2024 — Jul 2024 [monthly]
Recruiting NA
-
Mar 2024 — Jun 2024 [monthly]
Recruiting NA
▶ Show 6 earlier versions
-
Jun 2023 — Mar 2024 [monthly]
Recruiting NA
-
Apr 2023 — Jun 2023 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Dec 2022 — Apr 2023 [monthly]
Not Yet Recruiting NA
-
Sep 2022 — Dec 2022 [monthly]
Not Yet Recruiting NA
-
May 2022 — Sep 2022 [monthly]
Not Yet Recruiting NA
-
Apr 2022 — May 2022 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Umbria Bioengineering Technologies
For direct contact, visit the study record on ClinicalTrials.gov .